Clinical Trial Update: The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)

View source ↗

Summary

An NHLBI-sponsored clinical trial update reports the completion of the Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI). The study exam…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease
• Metabolic Syndrome
• Psoriasis

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Metabolic Disease, Cardiovascular Disease | Status: COMPLETED